A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemiaEsther Onecha, Rosa Ayala, María Linares et al.|Haematologica|2018Cited by 51
Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1Jordi Esteve, Marı́a Rozman, José‐Tomás Navarro et al.|Annals of Hematology|2014Cited by 29
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on TreatmentNerea Vega‐García, Mireia Camós, Antonio Jiménez‐Velasco et al.|Frontiers in Pediatrics|2021Cited by 9